Zydus Lifesciences

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue4,0023,7853,6553,8004,073
Expenses3,2033,2053,0862,9603,423
EBITDA798.60580.30569.30840.50649.40
EBIT625.30395.50386.10678.20468.70
Profit Before Tax802.90603.50599.00881.00681.00
Net Profit587.203,002500.40397.40518.30
Financial Ratios
Operating Profit Margin19.96%15.33%15.58%22.12%15.95%
Net Profit Margin14.67%79.33%13.69%10.46%12.73%
Earning Per Share (Diluted)5.845.734.894.885.16
Dividends Per ShareNANANA2.50NA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI